HIGHLIGHTS
- who: Xiaobo Zhang from the ACardarelli, United States have published the research work: Novel irreversible electroporation ablation (Nano-knife) versus radiofrequency ablation for the treatment of solid liver tumors: a comparative, randomized, multicenter clinical study, in the Journal: (JOURNAL)
- what: This study evaluated the safety and efficacy of a new National Medical Products Administration (NMPA)-approved IRE-based device for ablation of malignant tumors of the liver and compared its effects on a RFA control group of patients who received RFA. In the present trial, the authors found using a novel IRE therapeutic device that . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.